Clinical Lab Molecular Diagnostics Test using QX200 ddPCR Instr.

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition for a Clinical Laboratory Molecular Diagnostics Test using QX200 ddPCR Instrument. The Molecular Diagnostics Laboratory of the Laboratory of Pathology performs molecular testing to assist in the diagnosis of a variety of cancers. The laboratory develops tests that assist in pathologic diagnosis, predict prognosis, and identify potential targets for rational personalized therapies. • The contract will be awarded to Nexus Group LLC. • The NAICS code for this procurement is 334516. • The size standard for this procurement is $34M. • The contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-99-1, July 16, 2018. • The acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).